Viva Biotech Holdings (OTCMKTS:VBIZF – Get Free Report) shares rose 6.2% during mid-day trading on Friday . The company traded as high as $0.2027 and last traded at $0.2027. Approximately 5,000 shares traded hands during mid-day trading, an increase of 400% from the average daily volume of 1,000 shares. The stock had previously closed at $0.1908.
Viva Biotech Stock Performance
The stock’s 50 day simple moving average is $0.34 and its 200 day simple moving average is $0.30.
About Viva Biotech
Viva Biotech Ltd is a Shanghai-based contract research organization (CRO) providing integrated early-stage drug discovery services to the global pharmaceutical and biotechnology industries. The company’s offerings span target identification, fragment-based drug discovery, structure-based design, medicinal chemistry, high-throughput screening, in vitro ADME/Tox assays and antibody discovery. Viva Biotech leverages a proprietary fragment library and in-house structural biology capabilities to support hit identification and lead optimization across a broad range of therapeutic modalities.
With an emphasis on accelerating preclinical programs, the company combines X-ray crystallography, high-content cell-based assays and comprehensive pharmacokinetic profiling to help clients progress candidates from hit to lead.
Featured Articles
- Five stocks we like better than Viva Biotech
- 3 Under-The-Radar Small Caps Making New All-Time Highs
- 3 Ways to Target the Resources Powering AI and Data Centers
- Buffett Spent 60 Years Ignoring Tech and the Bill Is Coming Due
- Excited About Gold But Unsure of Its Trajectory? Try These 3 Approaches
Receive News & Ratings for Viva Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viva Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
